Found 435 matching trials
Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer PHASE4 The aim of this study was to evaluate the efficacy, safety and tolerability...
Show More Location
Breast Cancer Center Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences
Learn More & Join Trial
A Randomized Secondary Adjuvant Treatment Intervention Study Comparing Trastuzumab-Deruxtecan to SOC Therapy in eBC Patients With Molecular Relapse PHASE3 Prospective, multi-center, randomized, open label comparative Phase III stu...
Show More Location
University Clinic Ulm
Learn More & Join Trial
Efficacy of TQB2102 Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer. PHASE2 The aim of this study is to evaluate the efficacy and safety of TQB2102 com...
Show More Location
Henan cancer hospital
Learn More & Join Trial
Intrathecal Pertuzumab and Trastuzumab in Patients With New Untreated Asymptomatic or Low Symptomatic Brain Metastasis in HER2 Positive Breast Cancer PHASE1 The purpose of this research study is to determine how well pertuzumab and ...
Show More Location
Duke University Medical Center
Learn More & Join Trial
Short-course Trastuzumab, Pertuzumab with Taxanes in the Adjuvant Treatment of Early HER2-positive Breast Cancer PHASE2 The investigators plan to carry out a phase II, open-label, single-arm clin...
Show More Location
Shanghai Jiaotong University School of Medicine affiliated Ruijin Hospital
Learn More & Join Trial
Anti-HER2 Therapy + Fulvestrant/Capecitabine in Women With HR+, HER2+, Non-visceral Metastases Stage IV Breast Cancer PHASE3 The purpose of this study is to evaluate the effectiveness of anti-HER2 the...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study. PHASE2 This is a multicenter, two-arm, exploratory clinical study designed to eval...
Show More Location
The Fourth Hospital of Hebei Medical University
Learn More & Join Trial
Tumor Markers for Efficacy of Dual-Target Therapy in HER2+ Breast Cancer NA This is a prospective, randomized study to compare the efficacy of TP (Taxa...
Show More Learn More & Join Trial
Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel. PHASE3 This is a randomized, double-blind, multicenter trial,parallel control desi...
Show More Location
Fudan University Cancer Hospital
Learn More & Join Trial
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer PHASE3 This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Show More Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Learn More & Join Trial